A porcine model for fixed drug eruptions in humans: The case of antipyrine in the Yucatan micropig

Journal of Applied Toxicology

Volumn 26, Issue 1, 2006, Pages 1-4

  Pak, Yvonne ^a   Stollberg Zagar, Kathleen ^a   Mayersohn, Michael ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Animal model; Cutaneous reactions

Indexed keywords

PHENAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLISTER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; EOSINOPHIL; FIXED DRUG ERUPTION; LYMPHOCYTE; MALE; MINIPIG; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; DISEASE MODELS, ANIMAL; DRUG ERUPTIONS; HUMANS; MALE; SWINE; SWINE, MINIATURE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 31644439681     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.966     Document Type: Article

References (20)

1. Alanko K, Stubb S, Reitamo S. 1987. Topical provocation of fixed drug eruption. Br. J. Dermatol. 116: 561-567.
2. Allen JG, Galloway DB, Ehsanullah RSB, Ruane RJ. 1984. The effect of bromazepam (Lexotan) administration on antipyrine pharmacokinetics in humans. Xenobiotica 14: 321-326.
3. Allen JG, Alderson J, Galloway DB, Hallett C. 1987. The effect of midazolam (Hypnovel) administration on antipyrine pharmacokinetics in humans. Xenobiotica 17: 875-879.
4. Bourns DCG. 1889. Unusual effects of antipyrine. Br. Med. J. 2: 818-820.
5. Brocq L. 1894. Eruption erythemato-pigmentee fixe due a l'antipyrine. Ann. Dermatol. Venereol. 5: 308-313.
6. Chargin L, Leifer W. 1940. Fixed eruptions due to the arsphenamines. J. Invest. Dermatol. 3: 443-463.
7. Engelking LR, Lofstedt J, Blyden GT, Greenblatt DJ. 1987. Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly. Pharmacology 34: 192-200.
8. Felix RH, Comaish JS. 1974. The value of patch and other skin tests in drug eruptions. Lancet 1: 1017-1019.
9. Garcia-Doval I, Roson E, Feal C, De la Torre C, Rodriguez T, Cruces MJ. 2001. Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid. Acta. Dermatol. Venereol. 81: 450-451.
10. Ghislain PD, Ghislain E. 2002. Fixed drug eruption due to fluconazole: a third case. J. Am. Acad. Dermatol. 46: 467.
11. Kauppinen K. 1983. Rational performance of drug challenge in cutaneous hypersensitivity. Semin. Dermatol. 1: 227-230.
12. Kauppinen K, Alanko K. 1989. Oral provocation: uses. Semin. Dermatol. 8: 187-191.
13. Kauppinen K, Kariniemi AL. 1998. Clinical manifestations and histological characteristics. In Skin Reaction to Drugs, Kauppinen K, Alanko K, Hannuksela M, Maibach H (eds). CRC Press: New York; 25-50.
14. Lee A-Y. 2000. Fixed drug eruptions: Incidence, recognition, and avoidance. Am. J. Clin. Dermatol. 1: 277-285.
15. Mahboob A, Haroon TS. 1998. Drugs causing fixed eruptions: a study of 450 cases. Int. J. Dermatol. 37: 833-838.
16. Schick E, Weber L, Gall H. 1996. Topical and systemic provocation of fixed drug eruption due to phenazone. Contact Dermat. 35: 58-59.
17. Thankappan TP, Zachariah J. 1991. Drug-specific clinical pattern in fixed drug eruptions. Int. J. Dermatol. 30: 867-870.
18. Verbov J. 1972. Fixed drug eruption due to phenazone in a hypnotic. Br. J. Dermatol. 86: 438.
19. Vickers FF, Bowman TA, Dvorchik BH, Passananti GT, Hughes DM, Vesell ES. 1989. On the antipyrine test in laboratory animals: studies in the dog and monkey. Drug Metab. Dispos. 17: 160-165.
20. Yamashita N, Natsuaki M, Sagami S. 1989. Flare-up reaction on murine contact hypersensitivity: I. Description of an experimental model: Rechallenge system. Immunology 67: 365-369.